verified SJR 0,481 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Springer Nature

workspace_premium Q3 — Drug Discovery lock Subscription Unclaimed

Journal of Antibiotics

Journal of Antibiotics is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has a price of 2395 €. It has an SJR impact factor of 0,481 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,481.

Journal of Antibiotics focuses its scope in these topics and keywords: streptomyces, achromogenes, antibacterial, antibiotic, synthesis, mutant, peptide, isolation, structure, cephalosporin, ...

ISSN: 0021-8820

Editorial: Springer Nature

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,481 Q3

H-index 96

Tasa de Aceptación pie_chart

26% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

2.395 € Subscription

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,481

H-index

Docs (year)

105

Docs 3y

284

Total refs

3253

Cites 3y

696

Citable 3y

276

Cites/Doc 2y

2.21

Ref/Doc

30.98

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

An inoculum-dependent culturing strategy (IDC) for the cultivation of environmental microbiomes and the isolation of novel endophytic Actinobacteria

YM-215343, a Novel Antifungal Compound from Phoma sp. QN04621

Carbon catabolite regulation of gentamicin formation.

Candiplanecin, a new antibiotic from Ampullariella regularis subsp. mannitophila subsp. nov. II. Isolation, physico-chemical characterization and biological activities.

Biosynthetic genes for aminoglycoside antibiotics

Biosynthesis of the antibiotic actinorhodin. Analysis of blocked mutants of Streptomyces coelicolor.

BINDING OF BLASTICIDIN S TO RIBOSOMES

BE-24566B, a New Antibiotic Produced by Streptomyces violaceusniger.

Aureobasidins as New Inhibitors of P-Glycoprotein in Multidrug Resistant Tumor Cells.

Asenjonamides A-C, antibacterial metabolites isolated from Streptomyces asenjonii strain KNN 42.f from an extreme-hyper arid Atacama Desert soil

Antitumor activity of leptomycin B.

Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. II. Structures of laxaphycins A, B, D and E.

SHOW MORE ARTICLES

Antibacterial activity of efrotomycin.

"Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4'- and 4""-hydroxyl groups of the aminoglycoside antibiotics."

Aerocyanidin, a new antibiotic produced by Chromobacterium violaceum.

Abyssomicins G and H and atrop-Abyssomicin C from the Marine Verrucosispora Strain AB-18-032†

A Simple Screening System for Anti-HIV Drugs: Syncytium Formation Assay Using T-Cell Line Tropic and Macrophage Tropic HIV env Expressing Cell Lines. Establishment and Validation.

A novel series of milbemycin antibiotics from Streptomyces strain E225. II. Isolation, characterization, structure elucidation and solution conformations.

A Novel Antibiotic CJ-17,572 from a Fungus, Pezicula sp.

A Novel Amide N-Glycoside of Ansamitocins from Actinosynnema pretiosum

A new immunomodulator, FR-900483.

A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological properties.

A new antitumor antibiotic, stubomycin.

A macrophage-stimulating compound from a screen of microbial natural products

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.